The Russian Direct Investment Fund (RDIF) and Indian generic pharmaceutical company Hetero have agreed to produce more than 100 million doses of Russian-made Sputnik V Covid-19 vaccine per year on Indian soil.

Production is set to start at the beginning of next year, the RDIF, which funded the development of the Russian vaccine, said in a statement.

DETAILS TO FOLLOW

Source: RT